Dry Eye Treatment Market to Hit $9.3 Billion: Bausch + Lomb Acquires XIIDRA, New FDA Approvals Boost Options

Know More: https://www.alliedmarketresearch.com/dry-eye-syndrome-treatment-market

Global Dry Eye Syndrome Treatment Market Insights

The global dry eye syndrome treatment market is showing impressive growth, valued at $4.7 billion in 2022 and projected to nearly double, reaching $9.3 billion by 2032 at a CAGR of 7.1%. Dry eye syndrome, a common condition resulting from inadequate tear production or poor-quality tears, causes discomfort and inflammation in the eye, leading to symptoms like burning, redness, and a gritty feeling. Key factors such as the aging population, increasing screen time, and advancements in treatment options are driving market growth.

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/2807

Market Dynamics
• Prevalence and Diagnosis: High incidence of dry eye syndrome (DED) globally; about 38 million Americans are affected, with only half diagnosed.
• Aging Population: More people aged 65+ are affected, with over 54 million adults aged 65+ in the U.S., contributing significantly to the demand.
• Technological Advancements: Companies are innovating with new treatments, like Bausch + Lomb's FDA-approved MIEBO, a unique solution targeting tear evaporation.
• Rising Screen Time: Prolonged use of digital devices is leading to more cases of dry eye syndrome, notably in younger demographics.
• Increasing Access in Developing Markets: Markets in countries like China, Brazil, and India are expanding due to better healthcare access and rising electronic device use.

Key Segments
1. By Drug:
• Lubricants: Basic relief options for mild cases.
• Dry Eye Syndrome Drugs: Dominated the market in 2022 and expected to grow due to high demand from aging populations and those frequently using screens.
2. By Dosage Form:
• Eye Drops: Leading the market segment due to ease of use and effective symptom relief.
• Ointments: Alternative for sustained moisture but less frequently used than drops.
3. By Distribution Channel:
• Retail Pharmacies: Dominate the market due to accessibility.
• Online Providers: Gaining traction, especially in regions with limited access to in-store treatments.
4. By Region:
• North America: Largest market in 2022, driven by high diagnosis rates and the presence of leading companies.
• Asia-Pacific: Expected to grow fastest due to a high population base and the rising adoption of innovative treatment methods.

Competitive Landscape
• Key Players: Major companies like AbbVie, Viatris, Novartis AG, and Bausch & Lomb are focusing on product development and acquisitions.
• Recent Acquisitions: Bausch + Lomb acquired XIIDRA from Novartis, strengthening its portfolio in non-steroidal eye treatments.
• FDA Approvals: Products like MIEBO and VEVYE have received FDA approval, offering patients new and targeted relief options.

Challenges
• Awareness and Diagnosis Gaps: Low diagnosis rates in certain regions hinder market growth.
The global dry eye syndrome treatment market is set to grow steadily over the coming decade, with expanding demand for advanced and effective treatments to cater to a diverse patient population across various regions.

𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/2807

Contact:

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog:
https://blog.alliedmarketresearch.com
Follow Us on | Facebook | LinkedIn | YouTube |

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.